DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "Stem Cells Pipeline Highlights - 2017" drug pipelines to their offering.
This report, Stem Cells Pipeline Highlights - 2017, provides the most up-to-date information on key pipeline products in the global Stem Cells market. It covers emerging therapies for Stem Cells in active clinical development stages, including early- and late-stage clinical trials. The pipeline data presented in this report helps executives for tracking competition, identifying partners, evaluating opportunities, formulating business development strategies, and executing in-licensing and out-licensing deals.
Clinical Trial Stages:
The report provides Stem Cells pipeline products by clinical trial stages, including both early- and late-stage development - phase 3 clinical trials, phase 2 clinical trials, phase 1 clinical trials, preclinical research, and discovery stage.
Drug Mechanism Classes:
The report provides Stem Cells pipeline products by their dominant mechanism of action. This helps executives categorize products based on their drug class and also assess the strengths and weaknesses of compounds.
Company:
The report provides Stem Cells pipeline products by the company.
Short-Term Launch Highlights:
Find out which Stem Cells pipeline products will be launched in the US and Ex-US till 2020.
Key Topics Covered:
1. Stem Cells Pipeline by Stages
2. Stem Cells Pipeline by Drug Class
3. Stem Cells Pipeline by Company
4. Stem Cells Phase 3 Clinical Trial Insights
5. Stem Cells Phase 2 Clinical Trial Insights
6. Stem Cells Phase 1 Clinical Trial Insights
7. Stem Cells Preclinical Research Insights
8. Stem Cells Discovery Stage Insights
9. Appendix
10. Research Methodology
For more information about this drug pipelines report visit http://www.researchandmarkets.com/research/vmxzvg/stem_cells.
